{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:07:40Z","timestamp":1790719660338,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1741-7015-7-73","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T19:14:13Z","timestamp":1259781253000},"source":"Crossref","is-referenced-by-count":21,"title":["Post-exposure prophylaxis during pandemic outbreaks"],"prefix":"10.1186","volume":"7","author":[{"given":"Seyed M","family":"Moghadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"R\u00f6st","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"251_CR1","unstructured":"World Health Organisation. [ http:\/\/www.who.int\/mediacentre\/news\/statements\/2009\/h1n1_pandemic_phase6_20090611\/en\/index.html ]"},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jac\/dkl376","volume":"58","author":"J Democratis","year":"2006","unstructured":"Democratis J, Pareek M, Stephenson I: Use of neuraminidase inhibitors to combat pandemic influenza. J Antimicrobl Chemother. 2006, 58: 911-915. 10.1093\/jac\/dkl376.","journal-title":"J Antimicrobl Chemother"},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","volume":"4","author":"M Lipsitch","year":"2007","unstructured":"Lipsitch M, Cohen T, Murray M, Levin BR: Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007, 4: e15-10.1371\/journal.pmed.0040015.","journal-title":"PLoS Med"},{"key":"251_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1126\/science.1122947","volume":"312","author":"RR Regoes","year":"2006","unstructured":"Regoes RR, Bonhoeffer S: Emergence of drug-resistant influenza virus: population dynamical considerations. Science. 2006, 312: 389-391. 10.1126\/science.1122947.","journal-title":"Science"},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1126\/science.1115717","volume":"309","author":"IM Longini Jr","year":"2005","unstructured":"Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME: Containing pandemic influenza at the source. Science. 2005, 309: 1083-1087. 10.1126\/science.1115717.","journal-title":"Science"},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature04017","volume":"437","author":"NM Ferguson","year":"2005","unstructured":"Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS: Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005, 437: 209-214. 10.1038\/nature04017.","journal-title":"Nature"},{"key":"251_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1098\/rspb.2007.0422","volume":"274","author":"ME Alexander","year":"2007","unstructured":"Alexander ME, Bowman CS, Feng Z, Gardam M, Moghadas SM, R\u00f6st G, Wu J, Yan P: Emergence of drug-resistance: implications for antiviral control of pandemic influenza. Proc R Soc B. 2007, 274: 1675-1684. 10.1098\/rspb.2007.0422.","journal-title":"Proc R Soc B"},{"key":"251_CR8","first-page":"433","volume":"58","author":"CDC","year":"2009","unstructured":"CDC: Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR. 2009, 58: 433-435.","journal-title":"MMWR"},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1073\/pnas.0307506101","volume":"101","author":"C Fraser","year":"2004","unstructured":"Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA. 2004, 101: 6146-6151. 10.1073\/pnas.0307506101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"251_CR10","doi-asserted-by":"publisher","first-page":"e1839","DOI":"10.1371\/journal.pone.0001839","volume":"3","author":"SM Moghadas","year":"2008","unstructured":"Moghadas SM, Bowman CS, Rost G, Wu J: Population-wide emergence of antiviral resistance during pandemic influenza. PLoS One. 2008, 3 (3): e1839-10.1371\/journal.pone.0001839.","journal-title":"PLoS One"},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2334-9-8","volume":"9","author":"J Arino","year":"2009","unstructured":"Arino J, Bowman CS, Moghadas SM: Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect Dis. 2009, 9: 8-10.1186\/1471-2334-9-8.","journal-title":"BMC Infect Dis"},{"key":"251_CR12","unstructured":"Centers for Disease Control and Prevention. [ http:\/\/www.cdc.gov\/h1n1flu\/recommendations.htm ]"},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1371\/journal.pone.0000012","volume":"1","author":"D Klinkenberg","year":"2006","unstructured":"Klinkenberg D, Fraser C, Heesterbeek H: The effectiveness of contact tracing in emerging epidemics. PLoS One. 2006, 1: e12-10.1371\/journal.pone.0000012.","journal-title":"PLoS One"},{"key":"251_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","volume":"9","author":"J Lessler","year":"2009","unstructured":"Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA: Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009, 9: 291-300. 10.1016\/S1473-3099(09)70069-6.","journal-title":"Lancet Infect Dis"},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1002\/sim.1912","volume":"23","author":"S Cauchemez","year":"2004","unstructured":"Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY: A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med. 2004, 23: 3469-3487. 10.1002\/sim.1912.","journal-title":"Stat Med"},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1524-4733.2008.00437.x","volume":"12","author":"B Sander","year":"2009","unstructured":"Sander B, Nizam A, Garrison LP, Postma MJ, Halloran ME, Longini IM: Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health. 2009, 12: 226-233. 10.1111\/j.1524-4733.2008.00437.x.","journal-title":"Value Health"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1086\/318537","volume":"183","author":"LV Gubareva","year":"2001","unstructured":"Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG: Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis. 2001, 183: 523-531. 10.1086\/318537.","journal-title":"J Infect Dis"},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","volume":"20","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P: Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001, 20: 127-133. 10.1097\/00006454-200102000-00002.","journal-title":"Pediatr Infect Dis J"},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004, 364: 759-765. 10.1016\/S0140-6736(04)16934-1.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"251_CR20","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jac\/dki018","volume":"55","author":"P Ward","year":"2005","unstructured":"Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu(R)) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005, 55 (Suppl 1): i5-i21. 10.1093\/jac\/dki018.","journal-title":"J Antimicrob Chemother"},{"key":"251_CR21","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1056\/NEJMp058291","volume":"353","author":"A Moscona","year":"2005","unstructured":"Moscona A: Oseltamivir resistance - disabling our influenza defenses. N Engl J Med. 2005, 353: 2633-2636. 10.1056\/NEJMp058291.","journal-title":"N Engl J Med"},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJMp0900648","volume":"360","author":"A Moscona","year":"2009","unstructured":"Moscona A: Global transmission of oseltamivir-resistant influenza. N Engl J Med. 2009, 360: 953-956. 10.1056\/NEJMp0900648.","journal-title":"N Engl J Med"},{"key":"251_CR23","volume-title":"Mathematical Epidemiology of Infectious Diseases","author":"O Diekmann","year":"2000","unstructured":"Diekmann O, Heesterbeek JAP: Mathematical Epidemiology of Infectious Diseases. 2000, Chichester: Wiley"},{"key":"251_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3201\/eid1209.041344","volume":"9","author":"R Gani","year":"2005","unstructured":"Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S: Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis. 2005, 9: 1355-1362.","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"251_CR25","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1126\/science.1176062","volume":"324","author":"C Fraser","year":"2009","unstructured":"Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C, WHO Rapid Pandemic Assessment Collaboration: Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009, 324 (19): 1557-1561. 10.1126\/science.1176062.","journal-title":"Science"},{"key":"251_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1750-2659.2009.00100.x","volume":"3","author":"B Pourbohloul","year":"2009","unstructured":"Pourbohloul B, Ahued A, Davoudi B, Meza R, Meyers LA, Skowronski DM, Villase\u00f1or I, Galv\u00e1n F, Cravioto P, Earn DJ, Dushoff J, Fisman D, Edmunds WJ, Hupert N, Scarpino SV, Trujillo J, Lutzow M, Morales J, Contreras A, Ch\u00e1vez C, Patrick DM, Brunham RC: Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respiratory Viruses. 2009, 3: 215-222. 10.1111\/j.1750-2659.2009.00100.x.","journal-title":"Influenza Other Respiratory Viruses"},{"key":"251_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature03063","volume":"432","author":"CE Mills","year":"2004","unstructured":"Mills CE, Robins JM, Lipsitch M: Transmissibility of 1918 pandemic influenza. Nature. 2004, 432: 904-906. 10.1038\/nature03063.","journal-title":"Nature"},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1073\/pnas.0601266103","volume":"103","author":"TC Germann","year":"2006","unstructured":"Germann TC, Kadau K, Longini IM, Macken CA: Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA. 2006, 103: 5935-5940. 10.1073\/pnas.0601266103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jama.285.6.748","volume":"285","author":"R Welliver","year":"2001","unstructured":"Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS, for the Oseltamivir Post-Exposure Prophylaxis Investigator Group: Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001, 285: 748-754. 10.1001\/jama.285.6.748.","journal-title":"JAMA"},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1086\/381128","volume":"189","author":"FG Hayden","year":"2004","unstructured":"Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J: Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis. J Infect Dis. 2004, 189: 440-449. 10.1086\/381128.","journal-title":"J Infect Dis"},{"issue":"6","key":"251_CR31","doi-asserted-by":"publisher","first-page":"e2362","DOI":"10.1371\/journal.pone.0002362","volume":"3","author":"JM McCaw","year":"2008","unstructured":"McCaw JM, Wood JG, McCaw CT, McVernon J: Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs. PLoS One. 2008, 3 (6): e2362-10.1371\/journal.pone.0002362.","journal-title":"PLoS One"},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3201\/eid1510.081129","volume":"15","author":"C van den Dool","year":"2009","unstructured":"Dool van den C, Hak E, Bonten MJM, Wallinga J: A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes. Emerg Infect Dis. 2009, 15: 1547-1555.","journal-title":"Emerg Infect Dis"},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/molbev\/msm103","volume":"24","author":"L Simonsen","year":"2007","unstructured":"Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, Holmes EC: The genesis and spread of reassortment human influenza A\/H3N2 viruses conferring adamantane resistance. Mol Biol Evol. 2007, 24: 1811-1820. 10.1093\/molbev\/msm103.","journal-title":"Mol Biol Evol"},{"key":"251_CR34","unstructured":"World Health Organisation. [ http:\/\/www.who.int\/csr\/don\/2009_09_25\/en\/index.html ]"},{"key":"251_CR35","first-page":"969","volume":"58","author":"Centers for Disease Control and Protection","year":"2009","unstructured":"Centers for Disease Control and Protection: Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR. 2009, 58: 969-972.","journal-title":"MMWR"},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jtbi.2009.03.029","volume":"259","author":"ME Alexander","year":"2009","unstructured":"Alexander ME, Dietrich SM, Hua Y, Moghadas SM: A comparative evaluation of modelling strategies for the effect of treatment and host interactions on the spread of drug resistance. J Theoret Biol. 2009, 259: 253-263. 10.1016\/j.jtbi.2009.03.029.","journal-title":"J Theoret Biol"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1098\/rsif.2007.1126","volume":"4","author":"F Debarre","year":"2007","unstructured":"Debarre F, Bonhoeffer S, Regoes RR: The effect of population structure on the emergence of drug resistance during influenza pandemics. J R Soc Interface. 2007, 4: 893-906. 10.1098\/rsif.2007.1126.","journal-title":"J R Soc Interface"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/aje\/kwj362","volume":"165","author":"ME Halloran","year":"2007","unstructured":"Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS: Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2007, 165: 212-221. 10.1093\/aje\/kwj362.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-7-73\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T15:28:55Z","timestamp":1468855735000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-7-73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-7-73","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"73"}}